Sentence examples for 1 srd from inspiring English sources

Over all the bifunctional catalysts with a Cu/ZnO/Al2O3 to zeolite weight ratio of 1, SRD was dominantly occurred, and H-ZSM-5 based bifunctional catalyst showed the highest SRD performance, i.e., DME conversion of over 95% and H2 yield of about 80%.

When p H p≫N0 or at high SNR, i.e., P s ≫N0 and P r ≫N0, we can have the following approximation: ς sd 2 ≈ σ sd 2, ς se 2 ≈ σ se 2, ς srd 2 ≈ σ srd 2, ς sre 2 ≈ σ sre 2. Suppose BSPK or QPSK modulation is adopted, and thus, p H p=K. Also assume that σ sd 2 = σ sr 2 = σ rd 2 = σ h 2, σ se 2 = σ re 2 = σ g 2. (70).

A group of 2 SRD and 2 SR CPUs is known as a Compute Unit (CU) and includes a local interconnection to let direct access between them.

The following factors were identified as predictors of treatment success: the presence of SRD [RR 4,8 (1,7-13,9)], SRD and ILF [RR 12,8 (1,9-87,6)], Cmin >2 mg/L [RR 2,3 (1,3-4)], and the presence of a significant extracorporeal clearance (> 25%) [RR 5,3 (1,9-14,8)], p < 0,01.

A total of 60 SRD patients were included with diagnostic of infection (40%), acute exacerbation of SRD (16.7%), iatrogenic complication (16.7%), cardiovascular complication (15%), and miscellaneous (11.7%).

As shown in Fig.  4b, SRD cells expressing NESH/Abi-3, but not Abi-1 or Abi-2, showed somewhat reduced motility compared with the parent SRD cells.

To determine whether or not the observed effects were definitely due to the inhibition of c-Abl kinase, we knocked down c-Abl in Abi-1 Abi-2, or NESH/Abi-3-expressing SRD cells and then analyzed the invadopodia formation.

During follow-up, 22 eyes (18.3 %) developed macular complications including macular edema (ten eyes, 8.3 %), SRD (four eyes, 3.3 %), active retinitis (two eyes, 1.6%%), severe macular atrophy (two eyes, 1.6%%), macular ischemia (three eyes, 2.5 %), macular hole (one eye, 0.8 %), epiretinal membrane (two eyes, 1.6%%), and subretinal fibrosis (one eye, 0.8 %).

Macular complications included macular edema (ten eyes, 8.3 %), SRD (four eyes, 3.3 %), active retinitis (two eyes, 1.6 %), macular ischemia (three eyes, 2.5 %), epiretinal membrane (two eyes, 1.6 %), and branch retinal vein occlusion involving the macula (two eyes, 1.6 %).

Group (G) 0: both normal, G1: ILF or SRD, G2: both.

Similar to in the case of NIH3T3 cells, the level of expression of the Abi-1 protein was remarkably reduced in NESH/Abi-3-expressing SRD cells (Fig.  4a, top row, lane 4).